Schrodinger (SDGR)

• Market cap: $1.44B
• 1 day: -0.15%
• 5 days: -7.41%
• 1 month: -11.52%
• 3 months: 4.34%
• 6 months: 1.65%
• Year to date: -43.84%
• 1 year: -46.83%
• 5 years: -31.11%
• 10 years: -31.11%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Employees: 787

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

89% more call options, than puts

Call options by funds: $14.2M | Put options by funds: $7.55M

0% less funds holding

Funds holding: 205 [Q2] → 204 (-1) [Q3]

3% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 34

2.18% less ownership

Funds ownership: 96.69% [Q2] → 94.51% (-2.18%) [Q3]

6% less capital invested

Capital invested by funds: $1.19B [Q2] → $1.12B (-$72.2M) [Q3]

13% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 72

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $28 42% upside
• Avg. target: $28 42% upside
• High target: $28 42% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

BMO Capital Gary Nachman 46% 1-year accuracy 6 / 13 met price target

42% upside $28

Outperform Maintained

13 Nov 2024